Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 253

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 253
---
>

Our board of directors has
concluded that our current leadership structure is appropriate at this time. However, our board of directors will continue to periodically
review our leadership structure and may make such changes in the future as it deems appropriate.

Role of Board in Risk Oversight

Our board of directors has
responsibility for the oversight of our risk management processes and, either as a whole or through its committees, regularly discusses
with management our major risk exposures, their potential impact on our business and the steps we take to manage them. The risk oversight
process includes receiving regular reports from board committees and members of senior management to enable our board of directors to
understand our risk identification, risk management and risk mitigation strategies with respect to areas of potential material risk,
including operations, finance, legal, regulatory, strategic and reputational risk.

The Audit Committee reviews
information regarding liquidity and operations, and oversees our management of financial risks. It also reviews information and policies
related to information technology risk, including cyber-security and incident response planning. Periodically, the Audit Committee reviews
our policies with respect to risk assessment, risk management, loss prevention and regulatory compliance. Oversight by the Audit Committee
includes direct communication with our external auditors, and discussions with management regarding significant risk exposures and the
actions management has taken to limit, monitor or control such exposures. The Compensation Committee is responsible for assessing whether
any of our compensation policies or programs has the potential to encourage excessive risk-taking. The nominating and corporate governance
committee manages risks associated with the independence of the board of directors, corporate disclosure practices and potential conflicts
of interest. While each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire
board of directors is regularly informed through committee reports about such risks. Matters of significant strategic risk are considered
by our board of directors as a whole.

Committees of the Board of Directors

The standing committees
of our board of directors include the Audit Committee, a Compensation Committee, and a nominating and corporate governance committee,
each of which operates under a charter that has been approved by our board of directors. Such charters are available on our website at
www.cero.bio/investors. The reference to our website address does not constitute incorporation by reference of the information
contained at or available through our website. We have included our website address as an inactive textual reference only.

Audit Committee

The members of our Audit
Committee are Mr. Byrnes, Dr. Rolfe and Mr. Patel.